Afatinib in EGFR+NSCLC (Recurrent or Stage IV) - Patients With Poor Performance Status (ECOG 2 or 3)
Clinical trial NCT02695290 · TERMINATED
Trial details
- NCT number
- NCT02695290
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-17
- Primary completion
- 2016-08-26
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.